MR-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMR-101
Drug Alias Namerepurposed VMAT2 inhibitor (Shinkei Therapeutics)MR-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsTardive DyskinesiaDyskinesiasTourette Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSHINKEI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSHINKEI Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsTardive DyskinesiaDyskinesiasTourette Syndrome

Other Information

ATC CodeN/A
Related LinksN/A